Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (2nd ed.)
Researchers from the University of Southern Denmark collaborated with Novo Nordisk, the pharmaceutical company behind semaglutide (marketed as Wegovy for weight loss and Ozempic for diabetes control), to analyze data from Danish health registries
Stable composition, ensuring accurate research use
Ozempic can also be prescribed off-label for chronic weight management
In addition, some participants participated in lifestyle intervention, while others did not
Product Hopping: The Clinical Conversion Strategy Product hopping involves reformulating a drug to create a new version with clinically meaningful advantages, launching that version with fresh IP protection, and migrating patients to the new formulation before the original goes generic